GB201009145D0 - Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies - Google Patents
Humanized anti-Venezuelan equine encephalitis virus recombinant antibodiesInfo
- Publication number
- GB201009145D0 GB201009145D0 GBGB1009145.2A GB201009145A GB201009145D0 GB 201009145 D0 GB201009145 D0 GB 201009145D0 GB 201009145 A GB201009145 A GB 201009145A GB 201009145 D0 GB201009145 D0 GB 201009145D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- humanized anti
- encephalitis virus
- recombinant antibodies
- equine encephalitis
- venezuelan equine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010014611 Encephalitis venezuelan equine Diseases 0.000 title 1
- 208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 title 1
- 201000009145 Venezuelan equine encephalitis Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002607771A CA2607771A1 (en) | 2007-11-01 | 2007-11-01 | Humanized anti-venezuelan equine encephalitis virus recombinant antibody |
PCT/CA2008/001940 WO2009055936A1 (en) | 2007-11-01 | 2008-11-03 | Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
Publications (5)
Publication Number | Publication Date |
---|---|
GB201009145D0 true GB201009145D0 (en) | 2010-07-14 |
GB2467491A GB2467491A (en) | 2010-08-04 |
GB2467491A8 GB2467491A8 (en) | 2010-12-22 |
GB2467491B GB2467491B (en) | 2013-03-20 |
GB2467491C GB2467491C (en) | 2013-03-27 |
Family
ID=40589892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201009145A Expired - Fee Related GB2467491C (en) | 2007-11-01 | 2008-11-03 | Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies |
Country Status (3)
Country | Link |
---|---|
CA (2) | CA2607771A1 (en) |
GB (1) | GB2467491C (en) |
WO (1) | WO2009055936A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8501157B2 (en) | 2007-11-01 | 2013-08-06 | Her Majesty the Queen in right of Canada as represented by The Ministry of National Defence | Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies |
GB0916630D0 (en) * | 2009-09-22 | 2009-11-04 | Secr Defence | Antibody |
EP3281954A1 (en) | 2010-11-04 | 2018-02-14 | Boehringer Ingelheim International GmbH | Anti-il-23 antibodies |
EP3326649B1 (en) | 2012-05-03 | 2022-02-09 | Boehringer Ingelheim International GmbH | Anti-il-23p19 antibodies |
US10507241B2 (en) | 2014-07-24 | 2019-12-17 | Boehringer Ingelheim International Gmbh | Biomarkers useful in the treatment of IL-23A related diseases |
WO2016036918A1 (en) | 2014-09-03 | 2016-03-10 | Boehringer Ingelheim International Gmbh | Compound targeting il-23a and tnf-alpha and uses thereof |
TWI787942B (en) * | 2015-06-24 | 2022-12-21 | 日商Jcr製藥股份有限公司 | Anti-human transferrin receptor antibody that passes through blood-brain barrier |
US11130815B2 (en) | 2015-06-24 | 2021-09-28 | Jcr Pharmaceuticals Co., Ltd. | Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody |
CN107586335B (en) * | 2016-07-06 | 2020-12-29 | 中国科学院微生物研究所 | Humanized monoclonal antibody and application |
EA201991577A1 (en) | 2016-12-26 | 2019-12-30 | Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. | NEW ANTIBODIES AGAINST THE HUMAN TRANSFERRIN RECEPTOR, ABLE TO BREAK THE HEMATOENCEPHALIC BARRIER |
-
2007
- 2007-11-01 CA CA002607771A patent/CA2607771A1/en not_active Abandoned
-
2008
- 2008-11-03 WO PCT/CA2008/001940 patent/WO2009055936A1/en active Application Filing
- 2008-11-03 GB GB201009145A patent/GB2467491C/en not_active Expired - Fee Related
- 2008-11-03 CA CA2704119A patent/CA2704119C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2467491A (en) | 2010-08-04 |
CA2607771A1 (en) | 2009-05-01 |
WO2009055936A1 (en) | 2009-05-07 |
CA2704119C (en) | 2014-12-30 |
GB2467491C (en) | 2013-03-27 |
GB2467491A8 (en) | 2010-12-22 |
GB2467491B (en) | 2013-03-20 |
CA2704119A1 (en) | 2009-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2467491B (en) | Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies | |
HK1144440A1 (en) | Hepatitis c virus antibodies | |
EP2380976A4 (en) | Human anti-human influenza virus antibody | |
EP2304440A4 (en) | Novel monoclonal antibodies against hpv proteins | |
IL196806A0 (en) | Anti-myostatin antibodies | |
EP2501723A4 (en) | Hepatitis b virus specific antibody and uses thereof | |
ZA201009273B (en) | Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1 | |
ZA201005348B (en) | Humanized anti-c5ar antibodies | |
EP2331579A4 (en) | Monoclonal antibodies | |
RS56755B1 (en) | Anti-myostatin antibodies | |
ZA201008993B (en) | Anti-human interleukin-20 antibodies | |
IL210493A0 (en) | Chimeric respiratory syncytial virus polypeptide antigens | |
ZA201003131B (en) | Anti-rsv g protein antibodies | |
IL236236A (en) | Fam26f polypeptide antibodies | |
ZA201202227B (en) | Monoclonal antibodies | |
HK1154251A1 (en) | Humanized antibodies against human interferon alpha | |
SI2330131T1 (en) | Antibodies against HER2 truncated variant CTF-611 | |
EP2399934A4 (en) | Novel monoclonal antibody, and use thereof | |
IL199974A0 (en) | Humanized antibodies against cxcr3 | |
EP2484694A4 (en) | Monoclonal antibody against human hig-1 polypeptide | |
EP2004684A4 (en) | Hepatitis c virus neutralizing antibodies | |
HK1164345A1 (en) | Truncated cd20 protein, deltacd20 cd20 deltacd20 | |
EP2540742A4 (en) | Anti-cyr61 protein monoclonal antibodies and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20191103 |